Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase

Blood

Volumn 83, Issue 10, 1994, Pages 2922-2930

  Hsiao, Michael H ^a   Yu, Alice L ^a   Yeargin, Jo ^a   Ku, David ^a   Haas, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; EXON; GENE MUTATION; HUMAN; HUMAN CELL; INTRON; LEUKEMOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

EID: 0028295419     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v83.10.2922.2922     Document Type: Article

References (48)

1. Bishop JM: The molecular genetics of cancer. Science 235:305, 1987
2. Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083, 1989
3. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumour type. Nature 342:705, 1989
4. Iggo R, Gatter J, Bartek J, Lane D, Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 355:675, 1990
5. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD: P53: A frequent target for genetic abnormalities in lung cancer. Science 246:491, 1989
6. Bressac B, Kew M, Wands J, Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 350:429, 1991
7. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427, 1991
8. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, Vogelstein B: Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706, 1991
9. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC, Berchuck A: Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51:2979, 1991
10. Ahuja H, Bar-Eli D, Advani SH, Benchimol S, Cline MJ: Alteration in the p53 gene and the clonal evolution of the blast crisis of CML. Proc Natl Acad Sci USA 86:6783, 1989
11. Kelman Z, Prokocimer M, Peller S, Kahn Y, Rechavi G, Manor Y, Cohen A, Rotter V: Rearrangement in the p53 gene in Philadelphia chromosome positive chronic myelogeneous leukemia. Blood 74:2318, 1989
12. Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K, Koeffler HP: Mutations of the p53 gene in adult T-cell leukemia. Blood 79:477, 1992
13. Sugito S, Yamato K, Sameshima Y, Yokota J, Yano S, Miyoshi I: Adult T-cell leukemia: Structures and expression of the p53 gene. Int J Cancer 49:880, 1991
14. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, Friend SH: P53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10:5772, 1990
15. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ: Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 84:7716, 1987
16. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakemura Y, White R, Vogelstein B: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217, 1989
17. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355:846, 1992
18. Mashal R, Shtalrid M, Talpaz M, Kantarjian H, Smith L, Beran M, Cork A, Trujillo J, Gutterman J, Deisseroth A: Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood 75:180, 1990
19. Ahuja H, Bar-Eli M, Advani SH, Benchimol S, Cline MJ: Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci USA 86:6783, 1989
20. Soussi T, Jonveaux P: p53 gene alterations in human hematological malignancies: A review. Nouv Rev Fr Hematol 33:477, 1991
21. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM: p53 mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res 52:674, 1992
22. Shirasawa S, Urabe K, Yanagawa Y, Toshitani K, Iwama T, Sasazuki T: p53 gene mutations in colorectal tumors from patients with familial polyposis coli. Cancer Res 51:2874, 1991
23. Cheng J, Haas M: Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 10:5502, 1990
24. Harvey DM, Levine AJ: p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev 5:2375, 1991
25. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R: p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413, 1991
26. Jonveaux P, Berger R: Infrequent mutations in the p53 gene in primary human T-cell acute lymphoblastic leukemia. Leukemia 5:839, 1991
27. Yeargin J, Cheng J, Yu AL, Gjerset R, Bogart M, Haas M: p53 mutation in acute T-cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T-ALL cell lines. J Clin Invest 91:2111, 1993
28. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics 5:874, 1989
29. Buchman VL, Chumakov PM, Ninkina NN, Samarrina OP, Georgiev GP: A variation in the structure of the protein-coding region of the human p53 gene. Gene 70:245, 1988
30. Cabanillas F, Pathak S, Grant G, Hagemaister FB, McLaughlin P, Swan F, Rodrigues MA, Trujillo J, Cork A, Butler JJ, Katz R, Freireich EJ: Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. Am J Med 87:167, 1989
31. Chin KV, Ueda K, Pastan I, Gottesman MM: Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 255:459, 1992
32. Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V: Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6:4650, 1986
33. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7:961, 1987
34. Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP: A variation in the structure of the protein-coding region of the human p53 gene. Gene 70:245, 1988
35. Ahuja HG, Testa MP, Cline MJ: Variation in the protein coding region of the human p53 gene. Oncogene 5:1409, 1990
36. Calle-Martin O, Fabregat V, Romero M, Soler J, Vives J, Yague J: AccII polymorphism of the p53 gene. Nucleic Acids Res 18:4963, 1991
37. Yeargin J, Cheng J, Haas M: Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia. Leukemia 6:85S, 1992 (suppl 3)
38. Soussi T, Caron de Fromentel C, Sturtzbecher HW, Ullrich S, Jenkins J, May P: Evolutionary conservation of the biochemical properties of p53: Specific interaction of xenopus laevis p53 with SV40 large T antigen and mammalian heat shock proteins 70. J Virol 63:3894, 1989
39. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779, 1983
40. Caron de Fromentel C, Soussi T: TP53 tumor suppressor gene: A model for investigating human mutagenesis. Genes Chromosom Cancer 4:1, 1992
41. Cheng J, Haas M: Sensitivity of detection of heterozygous point mutations in p53 cDNA by direct PCR sequencing. PCR Methods Applications 1:199, 1992
42. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237, 1992
43. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80, 1992
44. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759, 1990
45. Folkman J, Hanahan D: Expression of angiogenic phenotype during development of murine and human cancer, in Brugge J (ed): Origins of Human Cancer: A Comprehensive Review. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1991, p 803
46. Renan MJ: How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7:139, 1993
47. Gjerset RA, Arya J, Volkman S, Haas M: Association of induction of a fully tumorigenic phenotype in murine radiation-induced T-lymphoma cells with loss of differentiation antigens, gain of CD44, and alterations in p53 protein levels. Mol Carcinog 5:190, 1992
48. Dittmer D, Pati S, Zambetti G, Chu S, Tereski AK, Moore M, Finlay C, Levine AJ: Gain of function mutations in p53. Nature Genet 4:42, 1993